EVMN
EVMN
NYSE · Biotechnology

Evommune Inc

$11.25
-0.10 (-0.88%)
As of Aug 8, 1:52 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 14 82%
Hold 3 18%
Sell 0 0%
Price Target
Analyst Price Target +573.8% upside
Low Target $52.19
Average Target $75.80
High Target $91.23
Current Price $11.25
Current
$11.25
Target
$75.80
$52.19 $75.80 avg $91.23
Scenario Analysis
Bear Case
$52.19
363.9%
Low target
Base Case
$75.80
+573.8%
Avg target
Bull Case
$91.23
+710.9%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$33.20
-66.1% from high
52-Week Low
$10.47
+7.4% from low
Target vs 52W High
$75.80
+128.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%